AWM
VTVT icon

Activest Wealth Management’s vTv Therapeutics VTVT Stock Holding History

Activest Wealth Management’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88K Hold
50
– – ﹤0.01% 865
2026
Q1 		$1.98K Hold
50
– – ﹤0.01% 956
2025
Q4 		$2K Hold
50
– – ﹤0.01% 891
2025
Q3 		$1.17K Hold
50
– – ﹤0.01% 855
2025
Q2 		$750 Hold
50
– – ﹤0.01% 804
2025
Q1 		$866 Hold
50
– – ﹤0.01% 786
2024
Q4 		$690 Hold
50
– – ﹤0.01% 495
2024
Q3 		$678 Hold
50
– – ﹤0.01% 476
2024
Q2 		$883 Buy
+50
New +$1.19K ﹤0.01% 441

Other funds holding VTVT

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Activest Wealth Management's VTVT Position: Q2 2026 in Review

Activest Wealth Management held its vTv Therapeutics (VTVT) position steady in Q2 2026 at 50 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #865.

Activest Wealth Management first reported a position in VTVT in Q2 2024 and has held it in 9 quarters since. The position peaked at $2K in Q4 2025. 3 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • Activest Wealth Management held 50 shares of vTv Therapeutics worth $1.88K as of Q2 2026.
  • Activest Wealth Management left its vTv Therapeutics share count unchanged in Q2 2026.
  • vTv Therapeutics made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #865 holding.
  • Activest Wealth Management first reported a position in vTv Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Activest Wealth Management's vTv Therapeutics position peaked at $2K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.